A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Keytruda is already approved by the FDA as a first-line therapy for PD-L1-positive metastatic cervical cancer in combination with chemo, with or without bevacizumab, and as a second-line therapy ...

“Recurrent or metastatic cervical cancer remains a significant challenge for patients, highlighting a critical unmet need for effective treatments that extend survival after relapse,” said Dr ...

If confirmed on larger case studies, the results of this study suggest that samples for Tg/CT mRNA and Tg protein measurements from CLN suspicious for metastatic thyroid cancer should be always ...

as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The approval means ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

On 4 February 2025, the global community observed World Cancer Day, a time to raise awareness about cancer prevention, ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...